Rabia Nagda, MD, of Texas Children’s Pediatrics, emphasizes that every environment where kids spend time should be built with fall risk in mind.
Confluence Health’s transitional care program enlists semi-retired and retired doctors to cut wait times, improve follow-up care and support care teams.
Find out how to participate in the CPT process by attending an Editorial Panel meeting or applying for a new or updated CPT code.
VeriCre™ helps overcome one of the most consequential challenges in the credentialing process—receiving verified data in applications quickly and reliably
The AMA backs bipartisan legislation to reissue 40,000 unused immigrant visas for physicians and nurses.
Giving feedback that harnesses surgical residents’ thirst for improvement is a winner at Geisinger. The approach is spreading to other specialties.
Find information about the responsibilities and terms of service for the Government Relations Advocacy Fellow (GRAF) and how to apply.
Medical students at Geisinger Commonwealth School of Medicine have a special chance to ease debt burdens and meet rural health needs. Find out how.
In residency and fellowship training, the business side of medicine often gets short shrift. Catch up on what you need to succeed in health care.
ACGME-required midyear reviews shouldn’t be taken for granted. The feedback might sting, but this is your chance to drill down for specifics.
Stay up to date on OBBBA implementation and related federal rulemaking with resources from the AMA.
Supporting the Improving Seniors’ Timely Access to Care Act, details on the FDA TEMPO model and more in the latest National Advocacy Update.
ChangeMedEd® is a national bi-annual conference that brings together innovative leaders across the medical education continuum to reimagine the way future physicians are trained. Learn more.
This two-day boot camp, April 13-14, 2026, will equip attendees with the time-saving tools and strategies to reform their organizations and enhance professional satisfaction.
Find out about the election bylaws and policies for being elected to the AMA House of Delegates.
Find out about opportunities for representation of Federation organizations in the AMA sections' annual and interim meetings.
Download PDFs of reports from the Council on Medical Education presented during the AMA Annual and Interim Meetings.
Download PDFs of reports on this topic from the Council on Medical Education presented during the AMA Interim and Annual Meetings.
Recap of the joint CME education event at I-25 and a review of the strategic goals for 2025-26.
Read current and past issues of WPS Members & News Highlights for the latest information on the work being done by WPS members and its leadership.
In the news: Changes to federal vaccine recommendations, GLP-1s and obesity-related cancer risk, uterine fibroids may raise heart disease risk and more.
Review a list of USAN Council-approved stems and which chemical and/or pharmacologic parameters have been established.
Substance misuse affects millions of Americans every year. The AMA is committed to addressing the root causes of substance misuse in America.
In the news: Radon and gestational diabetes risk, dementia trends, HMPV in the U.S., FDA action on nicotine in cigarettes and more.
With cannabis use on the rise, an AMA podcast series details cannabis pharmacology, screening tools and how to advise patients.
In the news: Surgeon General recommendation on warning labels on alcohol, first bird flu death in U.S., high drug overdose death rate and more.
The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about bird flu in 2025, norovirus and more.
The AMA applauds the Surgeon General’s work to make completely clear the link between alcohol consumption and increased cancer risk.
In the news: Tirzepatide approved for sleep apnea, mutations seen in bird flu virus, Systane eye drops recalled and more.
In the news: FDA recall on popular antidepressant, American adults living with chronic pain, fifth pig organ transplant in the U.S. and more.
Overdose deaths have plateaued, but multiple policy barriers are holding back further progress. Lawmakers should follow the evidence on what works to save lives.
